» Articles » PMID: 30442978

Amyloid β Toxic Conformer Has Dynamic Localization in the Human Inferior Parietal Cortex in Absence of Amyloid Plaques

Overview
Journal Sci Rep
Specialty Science
Date 2018 Nov 17
PMID 30442978
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Amyloid β (Aβ) plays a critical role in the pathogenesis of Alzheimer's disease. Nevertheless, its distribution and clearance before Aβ plaque formation needs to be elucidated. Using an optimized immunofluorescent staining method, we examined the distribution of Aβ in the post-mortem parietal cortex of 35 subjects, 30 to 65 years of age, APOE ε3/ε3, without AD lesions. We used 11A1, an antibody against an Aβ conformer which forms neurotoxic oligomers. 11A1 immunoreactivity (IR) was present in cortical neurons, pericapillary spaces, astrocytes and the extracellular compartment at 30 years of age. The percentage of neurons with 11A1 IR did not change with age, but the number and percentage of astrocytes with 11A1 IR gradually increased. Notably, the percentage of pericapillary spaces labeled with 11A1 IR declined significantly in the 5 decade of the life, at the same time that 11A1 IR increased in the extracellular space. Our findings indicate that the Aβ toxic conformer is normally present in various cell types and brain parenchyma, and appears to be constitutively produced, degraded, and cleared from the inferior parietal cortex. The decrease in pericapillary Aβ and the concomitant increase of extracellular Aβ may reflect an age-associated impairment in Aβ clearance from the brain.

Citing Articles

Proteasome localization and activity in pig brain and small molecule screening for activators.

Amrein Almira A, Chen M, El Demerdash N, Javdan C, Park D, Lee J Front Cell Neurosci. 2024; 18:1353542.

PMID: 38469354 PMC: 10925635. DOI: 10.3389/fncel.2024.1353542.


LC3/FtMt Colocalization Patterns Reveal the Progression of FtMt Accumulation in Nigral Neurons of Patients with Progressive Supranuclear Palsy.

Bakar Z, Bellier J, Yanagisawa D, Kato T, Mukaisho K, Tooyama I Int J Mol Sci. 2022; 23(1).

PMID: 35008961 PMC: 8745681. DOI: 10.3390/ijms23010537.


A brain proteomic signature of incipient Alzheimer's disease in young ε4 carriers identifies novel drug targets.

Roberts J, Varma V, An Y, Varma S, Candia J, Fantoni G Sci Adv. 2021; 7(46):eabi8178.

PMID: 34757788 PMC: 8580310. DOI: 10.1126/sciadv.abi8178.


Immunohistochemical Study of Mitochondrial Ferritin in the Midbrain of Patients with Progressive Supranuclear Palsy.

Bakar Z, Kato T, Yanagisawa D, Bellier J, Mukaisho K, Tooyama I Acta Histochem Cytochem. 2021; 54(3):97-104.

PMID: 34276103 PMC: 8275861. DOI: 10.1267/ahc.21-00019.


An RNA aptamer with potent affinity for a toxic dimer of amyloid β42 has potential utility for histochemical studies of Alzheimer's disease.

Murakami K, Obata Y, Sekikawa A, Ueda H, Izuo N, Awano T J Biol Chem. 2020; 295(15):4870-4880.

PMID: 32127399 PMC: 7152766. DOI: 10.1074/jbc.RA119.010955.


References
1.
Querfurth H, LaFerla F . Alzheimer's disease. N Engl J Med. 2010; 362(4):329-44. DOI: 10.1056/NEJMra0909142. View

2.
Heneka M, Carson M, El Khoury J, Landreth G, Brosseron F, Feinstein D . Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015; 14(4):388-405. PMC: 5909703. DOI: 10.1016/S1474-4422(15)70016-5. View

3.
Sakono M, Zako T . Amyloid oligomers: formation and toxicity of Abeta oligomers. FEBS J. 2010; 277(6):1348-58. DOI: 10.1111/j.1742-4658.2010.07568.x. View

4.
Izuo N, Kume T, Sato M, Murakami K, Irie K, Izumi Y . Toxicity in rat primary neurons through the cellular oxidative stress induced by the turn formation at positions 22 and 23 of Aβ42. ACS Chem Neurosci. 2012; 3(9):674-81. PMC: 3447395. DOI: 10.1021/cn300033k. View

5.
Nixon R . Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci. 2007; 120(Pt 23):4081-91. DOI: 10.1242/jcs.019265. View